APLS Next Earnings Date Notes

— Apellis Pharmaceuticals (APLS) is a commercial-stage biopharmaceutical company focused on developing innovative therapies for rare & serious diseases driven by uncontrolled complement system activation, specifically targeting the C3 protein. Its lead product, EMPAVELI (pegcetacoplan), is approved in the US & other markets for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) & geographic atrophy (GA) secondary to age-related macular degeneration, both of which represent large unmet medical needs. Key business metrics to focus on for Apellis include net product sales of EMPAVELI (and SYFOVRE, its ophthalmology brand), sequential & year-over-year revenue growth, market uptake, patient starts & discontinuations, as well as gross margin trends. Additionally, pipeline progress, regulatory milestones, & updates on safety—particularly given past concerns about rare adverse events with SYFOVRE—are crucial for assessing long-term sustainability. Monitoring R&D spending relative to revenue is also important to understand investment in future growth. Investors should listen closely to management's commentary on these topics during the earnings call, as they'll shape the thesis for APLS's growth trajectory. The next projected earnings date for APLS is 5/6/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

APLS Next Earnings Date FAQ

On this page we presented the APLS Next Earnings Date information for Apellis Pharmaceuticals along with recent past earnings dates. For Q4 of 2025, APLS reported earnings of -0.470/share, with the earnings report taking place on 2/24/2026. For Q3 of 2025, APLS reported earnings of 1.670/share, with the earnings report taking place on 10/30/2025. For Q2 of 2025, APLS reported earnings of -0.330/share, with the earnings report taking place on 7/31/2025. For Q1 of 2025, APLS reported earnings of -0.740/share, with the earnings report taking place on 5/7/2025. For Q4 of 2024, APLS reported earnings of -0.290/share, with the earnings report taking place on 2/28/2025. Based on these past earnings dates, the projected next earnings date for APLS is 5/6/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Apellis Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Apellis Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Apellis Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next APLS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up APLS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the APLS next earnings date.